NCT04238754View on ClinicalTrials.gov

Oral Cannabidiol for Opioid Withdrawal

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Opioid WithdrawalOpioid CravingOpioid Use Disorder
Interventions
DRUG

Epidiolex

Epidiolex 100 mg/mL Oral Solution

DRUG

Placebo

Cherry syrup oral solution

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Dalio Foundation

OTHER

lead

Johns Hopkins University

OTHER

NCT04238754 - Oral Cannabidiol for Opioid Withdrawal | Biotech Hunter | Biotech Hunter